Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
06/28/2001 | CA2394604A1 Substituted acylhydroxamic acids and method of reducing tnf.alpha. levels |
06/28/2001 | CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
06/27/2001 | EP1110958A1 Alpha-arylethylpiperazine derivatives as neurokinin antagonists |
06/27/2001 | EP1110950A1 Chromatographic separation of enantiomers of bicyclic lactames |
06/27/2001 | EP1110945A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
06/27/2001 | EP1109813A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
06/27/2001 | EP1109805A1 Inhibitors of bacterial nad synthetase |
06/27/2001 | EP1109785A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
06/27/2001 | EP1109784A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands |
06/27/2001 | EP0801059B1 Indole derivative |
06/27/2001 | EP0718281B1 Cyclohexanediurea derivative and process for producing the same |
06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
06/27/2001 | CN1301173A Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
06/27/2001 | CN1301161A Serotonergic 5HT receptor compounds for treating ocular and CNS disorders |
06/27/2001 | CN1067678C Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound |
06/27/2001 | CN1067550C Calcium receptor active molecules |
06/26/2001 | US6252112 Process for the preparation of an enantiomer of a (1R, 4S) or (1S, 4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene derivative |
06/26/2001 | US6252104 3,6-disubstituted-2-oxynaphthalene derivatives; raw materials for synthesis of such materials as dyes, pigments, photosensitive materials |
06/26/2001 | US6252084 Therapy for sepsis shock |
06/26/2001 | US6252078 Fungicides for the control of take-all disease of plants |
06/26/2001 | US6252077 1-(N′-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands |
06/26/2001 | US6251933 Seco precursors of cyclopropylindolines and their use as prodrugs |
06/26/2001 | US6251932 Immunophilin ligands |
06/26/2001 | US6251923 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation |
06/26/2001 | US6251917 Benzamidoaldehydes and their use as cysteine protease inhibitors |
06/26/2001 | US6251916 For therapy of pain |
06/26/2001 | US6251913 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
06/26/2001 | US6251830 Pesticides and herbicides |
06/21/2001 | WO2001044226A1 Serine protease inhibitors |
06/21/2001 | WO2001044204A1 Phenoxy and thiophenoxy acrylic acid compounds as herbicides |
06/21/2001 | WO2001044186A1 Substituted guanidine derivatives |
06/21/2001 | WO2001044185A1 Carbon monoxide-based synthesis of spla2 inhibitors |
06/21/2001 | WO2001044184A1 Synthesis of indole-containing spla2 inhibitors |
06/21/2001 | WO2001044182A2 New synthesis of spla2 inhibitors |
06/21/2001 | WO2001044172A1 Salicylamides as serine protease and factor xa inhibitors |
06/21/2001 | WO2001044167A1 Quaternary ammonium compounds and their use as anti-tussive agents |
06/21/2001 | WO2001043743A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
06/21/2001 | WO2001043741A1 Cytotoxic n-unsubstituted indoles and cyclopent(b)indoles and method of making and using same |
06/21/2001 | US20010004629 Improved toleration by crops, insecticidal and/or spectrum of action |
06/21/2001 | DE10061948A1 Lichtempfindliche Harzzusammensetzung A photosensitive resin composition |
06/21/2001 | DE10061947A1 Oximester-Photostarter Oxime ester photoinitiator |
06/21/2001 | CA2395474A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
06/21/2001 | CA2394639A1 Salicylamides as serine protease and factor xa inhibitors |
06/21/2001 | CA2394422A1 Phenoxy and thiophenoxy acrylic acid compounds as herbicides |
06/21/2001 | CA2393699A1 Quaternary ammonium compounds and their use as anti-tussive agents |
06/20/2001 | EP1109059A2 Oxonol infrared radiation sensitive compounds |
06/20/2001 | EP1107944A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
06/20/2001 | EP0757682B1 Benzofuran derivatives useful as inhibitors of bone resorption |
06/20/2001 | CN1300291A Modulators of protein tyrosine phosphatases |
06/20/2001 | CN1300281A Compounds with growth hormone releasing properties |
06/20/2001 | CN1300279A Modulators of protein tyrosine phosphatases |
06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
06/20/2001 | CN1299812A Oximate light initiator |
06/20/2001 | CN1067386C 5-heteroarylindole derivatives as benzodiazepine receptor site agnoists and analagonists |
06/20/2001 | CN1067378C N,N-diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propananine dimaleate |
06/19/2001 | US6248894 Fungicides for the control of take-all disease of plants |
06/19/2001 | US6248884 Particularly well suited for use in automated fluorescence-based dna sequencing systems using an excitation light source having a wavelength greater than about 630 nm, e.g., a helium-neon gas laser or a solid state diode laser. |
06/19/2001 | US6248775 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
06/19/2001 | US6248772 Indoloylguanidine derivatives |
06/19/2001 | US6248771 Formulations for hydrophobic pharmaceutical agents |
06/19/2001 | US6248753 Bicyclic compounds |
06/19/2001 | CA2013893C Tetrahydrobenz¬c,d|indole serotonin agonists |
06/15/2001 | CA2328376A1 Oxime ester photoinitiators |
06/15/2001 | CA2328342A1 Photosensitive resin composition |
06/14/2001 | WO2001042315A1 Substituted group 4 metal complexes, catalysts and olefin polymerization process |
06/14/2001 | WO2001042249A1 Olefin polymerization cocatalysts derived from group-15 compounds and processes using them |
06/14/2001 | WO2001042216A2 Caspase inhibitors and uses thereof |
06/14/2001 | WO2001042211A2 Detection of transmembrane potentials by optical methods |
06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
06/14/2001 | CA2646567A1 Substituted group 4 metal complexes, catalysts and olefin polymerization process |
06/14/2001 | CA2393562A1 Detection of transmembrane potentials by optical methods |
06/14/2001 | CA2391855A1 Olefin polymerization cocatalysts derived from group-15 compounds and processes using them |
06/13/2001 | EP1106605A1 Alpha1b-adrenergic receptor antagonists |
06/13/2001 | EP1105376A1 Oxindole derivatives as growth hormone releasers |
06/13/2001 | EP1105135A1 Antiviral indoleoxoacetyl piperazine derivatives |
06/13/2001 | EP0656892B1 Herbicidal 2- (4-heterocyclic-phenoxymethyl)phenoxy]-alkanoates |
06/13/2001 | DE19956414A1 Verfahren zur Herstellung von chiralen Aminen durch homogen katalysierte asymmetrische Hydrierung von Enaminen A process for the preparation of chiral amines by homogeneously catalyzed asymmetric hydrogenation of enamines |
06/13/2001 | CN1299357A Indole derivatives useful A.O. for the treatment of osteoporosis |
06/13/2001 | CN1299348A SPLA inhibitor compounds for treatment of disease |
06/13/2001 | CN1299347A Inhibitor of phospholipase enzymes |
06/13/2001 | CN1299345A Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
06/13/2001 | CN1299280A Indoly-1-3-glyoxylic acid derivatives with antitumoral activity |
06/13/2001 | CN1299279A Use of nicotinic receptor agonist |
06/13/2001 | CN1298872A Novel amino pyrroline compound, its prepn. method and pharmaceutical compositions contg. same |
06/13/2001 | CN1067071C Carboline derivatives |
06/13/2001 | CN1067068C Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists |
06/13/2001 | CN1067054C 1H-indole-3-glyoxylamide 5 PLA 2 inhibitors |
06/13/2001 | CN1067044C Novel tricyclic derivatives, their prepn. process |
06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
06/12/2001 | US6245775 Anticholesterol agents; cardiovascular disorders |
06/12/2001 | US6245768 Psychological disorders |
06/12/2001 | US6245761 Indolyl neuropeptide Y receptor antagonists |
06/12/2001 | US6245449 Material for organoelectroluminescence device and use thereof |
06/07/2001 | WO2001041512A1 Complexes of form l2mx as phosphorescent dopants for organic leds |
06/07/2001 | WO2001040401A1 Novel fluorescent carbazole derivative |
06/07/2001 | WO2001040188A1 Curcumin analogues for treating cancer |
06/07/2001 | WO2001040185A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
06/07/2001 | WO2001040183A1 1-aminoalkyl-1h-indoles for treating glaucoma |
06/07/2001 | WO2001040182A2 Solid pharmaceutical preparation |